JP Morgan Chase
NEOS

JP Morgan Chase’s Neos Therapeutics, Inc NEOS Stock Holding History

JP Morgan Chase’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14
Closed – – 5966
2020
Q2 		$0 Buy
+14
New +$11 ﹤0.01% 5873
2020
Q1 		– Sell
-95,590
Closed -$144K – 5909
2019
Q4 		$144K Buy
95,590
+90,696
+1,853% +$136K ﹤0.01% 4791
2019
Q3 		$7K Sell
4,894
-211,006
-98% -$341K ﹤0.01% 5545
2019
Q2 		$261K Buy
215,900
+204,481
+1,791% +$376K ﹤0.01% 4552
2019
Q1 		$30K Sell
11,419
-25,400
-69% -$59.6K ﹤0.01% 5297
2018
Q4 		$61K Sell
36,819
-230,598
-86% -$647K ﹤0.01% 5017
2018
Q3 		$1.3M Buy
267,417
+165,555
+163% +$939K ﹤0.01% 3745
2018
Q2 		$636K Buy
101,862
+96,879
+1,944% +$722K ﹤0.01% 4062
2018
Q1 		$41K Sell
4,983
-610
-11% -$5.82K ﹤0.01% 4887
2017
Q4 		$57K Sell
5,593
-8,156
-59% -$78.3K ﹤0.01% 4853
2017
Q3 		$120K Buy
+13,749
New +$104K ﹤0.01% 4253
2017
Q2 		– Sell
-13,681
Closed -$99K – 5344
2017
Q1 		$99K Buy
13,681
+4,120
+43% +$25.6K ﹤0.01% 4333
2016
Q4 		$56K Buy
+9,561
New +$64.7K ﹤0.01% 4528

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's NEOS Position: Q3 2020 in Review

JP Morgan Chase sold out of Neos Therapeutics, Inc (NEOS) in Q3 2020, closing a stake of 14 shares.

JP Morgan Chase first reported a position in NEOS in Q4 2016 and held it in 13 quarters. The position peaked at $1.3M in Q3 2018. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

  • JP Morgan Chase reported no remaining Neos Therapeutics, Inc position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Chase sold 14 Neos Therapeutics, Inc shares in Q3 2020.
  • JP Morgan Chase first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 13 quarters.
  • JP Morgan Chase's Neos Therapeutics, Inc position peaked at $1.3M in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.